| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |